Nancy Dvorin

Managing Editor

20 Years of Experience


@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: MedTech Strategist April 2023

Emerging cardiovascular companies are staking claims in pulsed field ablation and percutaneous ventricular assist devices. Biogen Digital Health identifies and validates digital biomarkers to accelerate neuroscience drug development; we look at their program to personalize multiple sclerosis care. Also in this issue, part 2 of our feature on Fogarty Innovation and profiles of start-ups Hyfe and Neuro One.

Read Article